Literature DB >> 12349912

Molecular cloning and tissue distribution of mRNA encoding porcine 5-HT7 receptor and its comparison with the structure of other species.

Pankaj Bhalla1, Pramod R Saxena, Hari S Sharma.   

Abstract

The effects of 5-hydroxytriptamine (5-HT, serotonin) are mediated via five main receptor types of which the 5-HT7 receptor is the most recently characterised member. The 5-HT7 receptor has been shown to participate in mediating cranial blood vessels dilatation that may result in migraine headache. We report here the cDNA cloning, sequencing and tissue distribution of porcine 5-HT7 receptor and illustrate its comparison with corresponding receptor of known species. Employing a combination of reverse transcriptase and inverse polymerase chain reaction we amplified and sequenced a full length cDNA from the porcine cerebral cortex. The deduced amino acid sequence comparison confirmed that the cloned porcine receptor belongs to 5-HT7 receptor as described for human and other species and showing overall homology of 92-96%. The expression of 5-HT7 receptor mRNA was observed in porcine central (cerebral cortex, trigeminal ganglion and cerebellum) as well as in peripheral (pulmonary and coronary arteries, superior vena cava and saphenous vein) tissues. The established cDNA sequence and tissue distribution of porcine 5-HT7 receptor will be helpful in exploring the role of this receptor in pathophysiological processes and to predict as a potential therapeutic target for antimigraine drug development.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12349912     DOI: 10.1023/a:1019959121602

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  33 in total

Review 1.  Pharmacological aspects of experimental headache models in relation to acute antimigraine therapy.

Authors:  P De Vries; C M Villalón; P R Saxena
Journal:  Eur J Pharmacol       Date:  1999-06-30       Impact factor: 4.432

2.  A novel, potent, and selective 5-HT(7) antagonist: (R)-3-(2-(2-(4-methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl) phen ol (SB-269970).

Authors:  P J Lovell; S M Bromidge; S Dabbs; D M Duckworth; I T Forbes; A J Jennings; F D King; D N Middlemiss; S K Rahman; D V Saunders; L L Collin; J J Hagan; G J Riley; D R Thomas
Journal:  J Med Chem       Date:  2000-02-10       Impact factor: 7.446

3.  Molecular cloning, pharmacological properties and tissue distribution of the porcine 5-HT(1B) receptor.

Authors:  P Bhalla; H S Sharma; X Ma; T Wurch; P J Pauwels; P R Saxena
Journal:  Br J Pharmacol       Date:  2001-07       Impact factor: 8.739

Review 4.  The 5-HT7 receptor: orphan found.

Authors:  R M Eglen; J R Jasper; D J Chang; G R Martin
Journal:  Trends Pharmacol Sci       Date:  1997-04       Impact factor: 14.819

Review 5.  Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy.

Authors:  P Tfelt-Hansen; P De Vries; P R Saxena
Journal:  Drugs       Date:  2000-12       Impact factor: 9.546

6.  The cloned human 5-HT7 receptor splice variants: a comparative characterization of their pharmacology, function and distribution.

Authors:  K A Krobert; T Bach; T Syversveen; A M Kvingedal; F O Levy
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2001-06       Impact factor: 3.000

7.  Assignment of the 5HT7 receptor gene (HTR7) to chromosome 10q and exclusion of genetic linkage with Tourette syndrome.

Authors:  J Gelernter; P A Rao; D L Pauls; M W Hamblin; D R Sibley; K K Kidd
Journal:  Genomics       Date:  1995-03-20       Impact factor: 5.736

Review 8.  Serotonin receptors: subtypes, functional responses and therapeutic relevance.

Authors:  P R Saxena
Journal:  Pharmacol Ther       Date:  1995-05       Impact factor: 12.310

Review 9.  Pharmacological opportunities and pitfalls in the therapy of migraine.

Authors:  A May; P J Goadsby
Journal:  Curr Opin Neurol       Date:  2001-06       Impact factor: 5.710

Review 10.  International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).

Authors:  D Hoyer; D E Clarke; J R Fozard; P R Hartig; G R Martin; E J Mylecharane; P R Saxena; P P Humphrey
Journal:  Pharmacol Rev       Date:  1994-06       Impact factor: 25.468

View more
  6 in total

Review 1.  Serotonin 5-HT7 receptor agents: Structure-activity relationships and potential therapeutic applications in central nervous system disorders.

Authors:  Marcello Leopoldo; Enza Lacivita; Francesco Berardi; Roberto Perrone; Peter B Hedlund
Journal:  Pharmacol Ther       Date:  2010-10-20       Impact factor: 12.310

Review 2.  Role of the 5-HT7 receptor in the central nervous system: from current status to future perspectives.

Authors:  Anne Matthys; Guy Haegeman; Kathleen Van Craenenbroeck; Peter Vanhoenacker
Journal:  Mol Neurobiol       Date:  2011-03-22       Impact factor: 5.590

3.  Evidence for 5-HT2B and 5-HT7 receptor-mediated relaxation in pulmonary arteries of weaned pigs.

Authors:  S Jähnichen; E Glusa; H H Pertz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-12-04       Impact factor: 3.000

Review 4.  The serotonin 5-HT7 receptors: two decades of research.

Authors:  Evelien Gellynck; Karen Heyninck; Kjetil W Andressen; Guy Haegeman; Finn Olav Levy; Peter Vanhoenacker; Kathleen Van Craenenbroeck
Journal:  Exp Brain Res       Date:  2013-09-17       Impact factor: 1.972

5.  Pharmacologic assessment of bovine ruminal and mesenteric vascular serotonin receptor populations.

Authors:  Miriam A Snider; David L Harmon; James L Klotz
Journal:  J Anim Sci       Date:  2018-04-14       Impact factor: 3.159

Review 6.  5-HT7 receptor signaling: improved therapeutic strategy in gut disorders.

Authors:  Janice J Kim; Waliul I Khan
Journal:  Front Behav Neurosci       Date:  2014-12-11       Impact factor: 3.558

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.